# Phase 3 infections trials recruiting: 91 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 91 trials in phase 3 for infections that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 3 infections trials: 91 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 4 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-3/infections

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 91
- Recruiting or not yet: 91
- Read on: November 19, 2026

## Trials

The 25 newest of 91, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 17, 2026 | NCT07943585 | A Phase Ⅲ Clinical Trial of an Investigative 24-valent Pneumococcal Polysaccharide Conjugate Vaccine | Reinovax Biologics Co., LTD | Phase 3 | Not yet recruiting | Pneumococcal Infectious Disease | 1,260 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07943585) |
| November 12, 2026 | NCT07932158 | Randomized, Multicenter, Non-inferiority Trial Comparing the Efficacy of Fosfomycin Versus Fluoroquinolones or Cotrimoxazole as Oral... | Assistance Publique - Hôpitaux de Paris | Phase 3 | Not yet recruiting | Prostatitis, Escherichia Coli Infection | 312 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07932158) |
| November 10, 2026 | NCT07928063 | Fosfomycin Trometamol Compared With an Alternative Active Antibiotic as Step-down Therapy for the Treatment of Acute Pyelonephritis Due to... | Assistance Publique - Hôpitaux de Paris | Phase 3 | Not yet recruiting | Escherichia Coli Infection, Elderly Women, Antibiotherapy, Pyelonephritis | 312 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07928063) |
| November 2, 2026 | NCT07908654 | A Study to Evaluate Efficacy, Immunogenicity and Safety of a Recombinant Respiratory Syncytial Virus Vaccine in Older Adults Aged 60 Years... | Guangzhou Patronus Biotech Co., Ltd. | Phase 3 | Not yet recruiting | Respiratory Syncytial Virus (RSV), Respiratory Syncytial Virus (RSV) Infection, RSV Vaccine | 25,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07908654) |
| October 29, 2026 | NCT07904429 | Keverprazan-Minocycline Dual Therapy of Different Durations Versus Bismuth Quadruple Therapy for Helicobacter Pylori Eradication. | Nanjing First Hospital, Nanjing Medical University | Phase 3 | Recruiting | Helicobacter Infection | 612 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07904429) |
| October 28, 2026 | NCT07901738 | Zopapogene Imadenovec for the Treatment of Recurrent Respiratory Papillomatosis in Children | Precigen, Inc | Phase 3 | Not yet recruiting | Recurrent Respiratory Papillomatosis (RRP), Juvenile-onset Recurrent Respiratory Papillomatosis, Papillomavirus... | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07901738) |
| October 20, 2026 | NCT07884240 | A Clinical Study to Assess the Efficacy of Weekly Doxycycline Prophylaxis to Reduce Bacterial Sexually Transmitted Infections (STI) in... | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 3 | Not yet recruiting | Sexually Transmitted Infection (STI), Gonorrhea, Syphilis, Chlamydia | 580 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07884240) |
| September 29, 2026 | NCT07848100 | Intralesional Acyclovir Versus Intralesional Zinc Sulphate in the Treatment of Plantar Warts | Assiut University | Phase 3 | Not yet recruiting | Warts, Plantar Warts, Human Papillomavirus Infection, Skin Diseases, Viral | 76 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07848100) |
| September 18, 2026 | NCT07827599 | A Study to Confirm Efficacy of a Single Dose of Baloxavir Marboxil in the Post-exposure Prophylaxis (PEP) of Influenza Virus Infection in... | Hoffmann-La Roche | Phase 3 | Recruiting | Influenza, Human, Respiratory Tract Infections, Post-exposure Prophylaxis | 325 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07827599) |
| September 17, 2026 | NCT07824310 | Immunogenicity and Safety of HPV-4 Vaccine With or Without Td Vaccine in Children | PT Bio Farma | Phase 3 | Not yet recruiting | Human Papillomavirus (HPV) Infection | 266 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07824310) |
| September 4, 2026 | NCT07804082 | A Double-Blind, Placebo-Controlled Study of Nebulized Bacteriophages in Patients With Ventilator-Associated Pneumonia Due to Pseudomonas... | Assistance Publique - Hôpitaux de Paris | Phase 3 | Not yet recruiting | Ventilator Associated Bacterial Pneumonia, Pseudomonas Aeruginosa Infection | 184 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07804082) |
| August 28, 2026 | NCT07793513 | Study of BK1803 in Healthy Infants | Tanabe Pharma Corporation | Phase 3 | Recruiting | Pertussis, Diphtheria, Tetanus, Poliomyelitis, Hepatitis B, Haemophilus Influenzae Type b | 344 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07793513) |
| August 28, 2026 | NCT07792096 | An Adaptive Platform Trial for Evaluation of Novel Treatment Regimens in Children and Adolescents With HIV in Africa | University College, London | Phase 3 | Not yet recruiting | HIV Infection | 800 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07792096) |
| August 25, 2026 | NCT07785843 | A Clinical Study of V503 in Chinese Females Who Have Previously Received a Bivalent Human Papillomavirus (HPV) Vaccine (V503-108) | Merck Sharp & Dohme LLC | Phase 3 | Recruiting | Papillomavirus Infections | 930 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07785843) |
| August 10, 2026 | NCT07754539 | A Study to Evaluate 20vPnC in Healthy Chinese Infants | Pfizer | Phase 3 | Recruiting | Pneumococcal Diseases | 1,250 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07754539) |
| July 17, 2026 | NCT07710872 | Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Infants and... | Sanofi | Phase 3 | Recruiting | Meningococcal Infection, Healthy Volunteers | 4,568 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07710872) |
| July 7, 2026 | NCT07686055 | Precision Management of Urinary Tract Symptoms in Older Women | Sponsor not shown (see the record) | Phase 3 | Recruiting | Urinary Tract Infection (Diagnosis) | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07686055) |
| July 6, 2026 | NCT07682961 | Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on... | Gilead Sciences | Phase 3 | Recruiting | HIV Infections | 590 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07682961) |
| July 1, 2026 | NCT07678229 | BRIDGE-NK: Immunotherapy Versus Chemotherapy Induction Followed by Autologous HSCT in Advanced NKTCL | Sponsor not shown (see the record) | Phase 3 | Recruiting | Extranodal NK/T-cell Lymphoma | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07678229) |
| June 24, 2026 | NCT07665476 | Naproxen Versus Placebo as Adjunct Treatment of Cellulitis | Ottawa Hospital Research Institute | Phase 3 | Not yet recruiting | Cellulitis, Skin Disease, Infectious, Infection, Skin and Soft Tissue Infections (SSTIs) | 884 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07665476) |
| June 22, 2026 | NCT07661316 | Combination Therapies for Trichuris Trichiura Infection in Schoolchildren in Honduras | Mundo Sano Foundation | Phase 3 | Not yet recruiting | Trichuriasis, Strongyloidiasis, Ascariasis, Hookworm Infection, Soil-Transmitted Helminthiasis | 368 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07661316) |
| June 22, 2026 | NCT07660198 | Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and Adolescents | Pfizer | Phase 3 | Recruiting | Pneumococcal Disease | 1,200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07660198) |
| June 22, 2026 | NCT07658976 | Duo: A Phase IIIb Individual-Level Randomized Controlled Trial of an Integrated Strategy | HIV Prevention Trials Network | Phase 3 | Not yet recruiting | HIV Infection, Sexually Transmitted Infection | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07658976) |
| June 8, 2026 | NCT07631364 | Efficacy of Temocillin Compared to Standard of Care in the Treatment of Neisseria Gonorrhoeae Infections | Assistance Publique - Hôpitaux de Paris | Phase 3 | Not yet recruiting | Neisseria Gonorrhoeae (Ng) Infections | 360 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07631364) |
| June 5, 2026 | NCT07629440 | A Study to Learn About How a New Pneumococcal Vaccine Works in Infants. | Pfizer | Phase 3 | Recruiting | Pneumococcal Disease | 3,230 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07629440) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Assistance Publique - Hôpitaux de Paris | 8 |
| [Pfizer](https://specstream.ai/data/clinical-trials/company/pfizer) | 7 |
| [Sanofi](https://specstream.ai/data/clinical-trials/company/sanofi) | 2 |
| UMC Utrecht | 1 |
| Ansun Biopharma, Inc. | 1 |
| [SymBio Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/symbio-pharmaceuticals) | 1 |
| Simcere Pharmaceutical Co., Ltd | 1 |
| [PT Bio Farma](https://specstream.ai/data/clinical-trials/company/pt-bio-farma) | 1 |
| Hospital de Niños R. Gutierrez de Buenos Aires | 1 |
| Reinovax Biologics Co., LTD | 1 |
| The University of Hong Kong | 1 |
| Major Extremity Trauma Research Consortium | 1 |
| Rabin Medical Center | 1 |
| Tanta University | 1 |
| [Grifols Therapeutics LLC](https://specstream.ai/data/clinical-trials/company/grifols-therapeutics-llc) | 1 |
| NPO Petrovax | 1 |
| [Gilead Sciences](https://specstream.ai/data/clinical-trials/company/gilead-sciences) | 1 |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 1 |
| Guangzhou Patronus Biotech Co., Ltd. | 1 |
| [Qilu Pharmaceutical Co., Ltd.](https://specstream.ai/data/clinical-trials/company/qilu-pharmaceutical-co-ltd) | 1 |
| HIV Prevention Trials Network | 1 |
| University Hospital, Rouen | 1 |
| TCM Biotech International Corp. | 1 |
| Helsinki University Central Hospital | 1 |
| University of Alabama at Birmingham | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 27 |
| France | 16 |
| China | 16 |
| Canada | 11 |
| Spain | 9 |
| Australia | 8 |
| Belgium | 8 |
| Germany | 8 |
| Denmark | 8 |
| Italy | 7 |
| Japan | 7 |
| Argentina | 7 |
| Brazil | 7 |
| South Africa | 7 |
| Finland | 6 |
| Netherlands | 6 |
| United Kingdom | 6 |
| Taiwan | 6 |
| Poland | 6 |
| Czechia | 5 |
| Hungary | 5 |
| Romania | 5 |
| South Korea | 5 |
| Bulgaria | 5 |
| Puerto Rico | 5 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Furniture manufacturers in the United States](https://specstream.ai/data/businesses/furniture-manufacturers/united-states)
- [Bottled water companies in the United States](https://specstream.ai/data/businesses/bottled-water-companies/united-states)
- [Taco restaurants in the United States](https://specstream.ai/data/businesses/taco-restaurants/united-states)
- [Mongolian restaurants in the United States](https://specstream.ai/data/businesses/mongolian-restaurants/united-states)
- [Fabric wholesalers in the United States](https://specstream.ai/data/businesses/fabric-wholesalers/united-states)
- [B2B science and technology companies in the United States](https://specstream.ai/data/businesses/b2b-science-and-technology-companies/united-states)
